Literature DB >> 16878481

Studies on an inactivated vaccine against rabies virus in domestic animals.

F Monaco1, P M Franchi, R Lelli.   

Abstract

An inactivated vaccine against rabies virus was prepared from the attenuated ATCC PV-12 viral rabbit Pasteur strain. The virus was grown on Baby Hamster Kidney (BHK21) cells, and the supernatant was purified by filtration and inactivated with beta-propriolactone. The inactivated product was checked according to the NHI and European Pharmacopoeia methods. Part of the product was then lyophilised and the other part was adjuvanted with Al(OH)3. Both parts were used to vaccinate and boost groups of horses, cattle and sheep at different intervals. Their immunogenicity was compared with a similar commercial product. Blood samples were collected on a regular basis and the antibody titre was determined by the Fluorescence Antibody Virus Neutralisation (FAVN) test. No significant differences were found between species after both inoculations even though the immune response increased in intensity and duration after the booster dose in all the animals tested and was stronger and lasted longer with the adjuvanted aliquot.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16878481

Source DB:  PubMed          Journal:  Dev Biol (Basel)        ISSN: 1424-6074


  4 in total

1.  A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.

Authors:  Zhenhai Chen; Ming Zhou; Xiudan Gao; Guoqing Zhang; Guiping Ren; Clement W Gnanadurai; Zhen F Fu; Biao He
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

2.  A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model.

Authors:  Jianqing Zhao; Yijing Zhang; Yixi Chen; Juntao Zhang; Jie Pei; Min Cui; Zhen F Fu; Ling Zhao; Ming Zhou
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

3.  Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs.

Authors:  Ming Zhou; Lei Wang; Songqin Zhou; Zhao Wang; Juncheng Ruan; Lijun Tang; Ziming Jia; Min Cui; Ling Zhao; Zhen F Fu
Journal:  Oncotarget       Date:  2015-11-17

4.  Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations.

Authors:  Ming Zhou; Guoqing Zhang; Guiping Ren; Clement W Gnanadurai; Zhenguang Li; Qingqing Chai; Yang Yang; Christina M Leyson; Wenxue Wu; Min Cui; Zhen F Fu
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.